Tyra Biosciences GAAP EPS of -$0.31 beats by $0.05
- Tyra Biosciences press release (NASDAQ:TYRA): Q4 GAAP EPS of -$0.31 beats by $0.05.
- Alan Fuhrman, CFO of TYRA, added, "TYRA is in a very strong financial position to begin 2023, with $251.2 million in cash and cash equivalents at year-end 2022, representing more than two years of expected cash runway to support our current development plans across our precision medicine platform."